Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis
PF McAuliffe, F Meric-Bernstam, GB Mills… - Clinical breast …, 2010 - Elsevier
Abstract The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin
(mTOR) pathway mediates multiple cellular functions critical to tumor initiation, progression …
(mTOR) pathway mediates multiple cellular functions critical to tumor initiation, progression …
Targeting PI3K/AKT/mTOR signaling pathway in breast cancer
Simple Summary PI3K signaling pathway plays an essential role in many cellular processes
and is frequently altered in breast cancer, leading to increased tumor growth and reduced …
and is frequently altered in breast cancer, leading to increased tumor growth and reduced …
Signal transduction pathways in breast cancer: the important role of PI3K/Akt/mTOR
MA Ortega, O Fraile-Martínez, Á Asúnsolo… - Journal of …, 2020 - Wiley Online Library
Breast cancer is the cancer with the highest prevalence in women and is the number‐one
cause of cancer mortality worldwide. Cell transduction is a fundamental process in the …
cause of cancer mortality worldwide. Cell transduction is a fundamental process in the …
The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
E Paplomata, R O'Regan - Therapeutic advances in medical …, 2014 - journals.sagepub.com
The phosphoinositide 3 kinase (PI3K)/Akt/mammalian (or mechanistic) target of rapamycin
(mTOR) pathway is a complicated intracellular pathway, which leads to cell growth and …
(mTOR) pathway is a complicated intracellular pathway, which leads to cell growth and …
PI3K/Akt/mTOR intracellular pathway and breast cancer: factors, mechanism and regulation
V Ruchi Sharma, G Kumar Gupta… - Current …, 2017 - ingentaconnect.com
Background: The most recurrent and considered second most frequent cause of cancer-
related deaths worldwide in women is the breast cancer. The key to diagnosis is early …
related deaths worldwide in women is the breast cancer. The key to diagnosis is early …
Current status and future perspectives of PI3K and mTOR inhibitor as anticancer drugs in breast cancer
X Zhang, X Li, J Zhang - Current cancer drug targets, 2013 - ingentaconnect.com
The PI3K/Akt/mTOR signaling pathway is involved in the inhibition of tumor cell apoptosis,
the promotion of cell survival, cell cycle regulation, tumor angiogenesis, invasion, and …
the promotion of cell survival, cell cycle regulation, tumor angiogenesis, invasion, and …
PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials
N Dey, P De, B Leyland-Jones - Pharmacology & therapeutics, 2017 - Elsevier
Breast cancer (BC) is the most common women cancer and second most common cause of
cancer death in women. A woman living in the United States has 12.3% lifetime risk of being …
cancer death in women. A woman living in the United States has 12.3% lifetime risk of being …
Targeting the PI3K/Akt/mTOR pathway for breast cancer therapy
J Cidado, BH Park - Journal of mammary gland biology and neoplasia, 2012 - Springer
Recent advances in genetics and genomics have revealed new pathways that are
aberrantly activated in many breast cancers. Chief among these genetic changes are …
aberrantly activated in many breast cancers. Chief among these genetic changes are …
Novel approaches for molecular targeted therapy of breast cancer: interfering with PI3K/AKT/mTOR signaling
T W. Grunt, G L. Mariani - Current cancer drug targets, 2013 - benthamdirect.com
Breast cancer is one of the most prevalent and devastating malignant diseases in women
worldwide. Fortunately, while breast cancer incidence is still increasing, its death rate is …
worldwide. Fortunately, while breast cancer incidence is still increasing, its death rate is …
The therapeutic potential of PI3K/Akt/mTOR inhibitors in breast cancer: rational and progress
A Bahrami, M Khazaei, S Shahidsales… - Journal of cellular …, 2018 - Wiley Online Library
Breast cancer (BC) is the most commonly diagnosed cancer in women. The PI3K/AKT/mTOR
pathway is among the most frequently dysregulated pathways in patients with BC. The …
pathway is among the most frequently dysregulated pathways in patients with BC. The …